Daily brief

Wednesday, 30 September 2026

The last 24 hours' hottest news in AI, sorted by field, each story with a line on why it matters.

Story of the day

The single most consequential story of the day.

lower cost than a pure frontier model
60%
Devin Fusion's cost per FrontierCode task
$1.35
FrontierCode score, near Fable 5's 64.9
63.1
Cognition's new valuation
$48B

Cognition launches Devin Fusion to cut AI coding costs

Cognition, the startup behind the Devin coding agent, unveiled Devin Fusion, a new way of mixing AI models that keeps frontier-level code quality while cutting costs by up to 60%. The system runs a top-tier model alongside a cheaper 'sidekick' model that handles routine work, only calling in the expensive model for planning and review. Cognition also confirmed it has raised more than $2 billion at a $48 billion valuation to build out the technology.

Why it's the story of the dayIt shows AI coding agents can get much cheaper without giving up code quality, a big deal for engineering teams' budgets.

Models & labs

New models, the labs behind them, and the rules they answer to.

Product

OpenAI's DevDay 2026 unveils more than 20 new features

OpenAI said DevDay 2026 was its biggest yet, with more than 20 announcements spanning ChatGPT, Codex, its models and new ways for people and AI to work together. It also opened ChatGPT, used by 1.2 billion people weekly, as a shared space where outside developers can launch new experiences.

Why it mattersIt signals OpenAI turning ChatGPT into a platform other companies build directly on top of.

OpenAI ↗
Model

ByteDance launches SeedRealtime, an audio-visual AI model

ByteDance's Seed team launched SeedRealtime, an AI model that can watch, listen and speak at once in real time, fusing audio, video and text in one system. The company says it halves conversational pacing problems compared with older cascaded systems and has already rolled it out at scale.

Why it mattersCombining sight, sound and speech in one model could make AI assistants feel far more natural to talk to.

ByteDance Seed ↗

Agents & coding

AI that acts on its own, and the tools developers build with.

Product

Cognition launches Devin Fusion to cut AI coding costs

Cognition, the maker of the Devin coding agent, launched Devin Fusion, a new multi-model harness for coding tasks. It pairs a frontier model with a cheaper 'sidekick' model, cutting costs by up to 60% on the FrontierCode benchmark while keeping performance close to top models like Fable 5 and Opus 5.

Why it mattersIt shows AI coding agents can get much cheaper without giving up code quality, cutting a major cost for engineering teams.

Cognition ↗
Funding

Cognition raises $2 billion at $48 billion valuation

Cognition has raised more than $2 billion at a $48 billion valuation, led by Andreessen Horowitz and Accel with many other investors joining. The company says its run-rate revenue grew from $492 million in May to almost $900 million, with customers including Nvidia, GE Aerospace, Citi and Mercedes-Benz.

Why it mattersThe huge valuation shows investors betting heavily on AI agents taking over more of software engineering.

Cognition ↗
Product

OpenAI launches 'dots', always-on AI agents for work

OpenAI introduced 'dots', always-on AI agents powered by GPT-6 Astra that get their own cloud computer and can work on tasks for hours without supervision. They connect to more than 4,000 apps and are rolling out on ChatGPT Pro, Business Premium and Enterprise plans.

Why it mattersIt marks OpenAI's push from chatbots that answer questions to agents that keep working on your behalf.

OpenAI ↗

Science & health

AI in biology, medicine, climate and maths.

Research

Microsoft launches Quine, an AI model of biology

Microsoft Research introduced Quine, a research system that pairs a multimodal 'world model' of biology with scientific tools, literature and researchers. Working with the Broad Institute of Harvard and MIT, the team used it to prioritise compounds that could shift tumour cells and validated several top candidates in lab tests.

Why it mattersIt's an early sign of AI directly speeding up the search for new cancer treatments, though Microsoft says it's for research only.

Microsoft ↗
Research

Isomorphic Labs charts a full AI drug-discovery pipeline

Isomorphic Labs, the Alphabet-backed drug discovery company founded with Demis Hassabis, laid out plans to take AI-designed medicines all the way to patients in the clinic. It says its Drug Design Engine, built on the AlphaFold work that won a 2024 Nobel Prize, now goes beyond structure prediction to design and optimise new drug candidates.

Why it mattersIt shows how far AI has moved from predicting proteins to actually designing medicines for real diseases.

Isomorphic Labs ↗

Quick hits

Smaller stories worth a glance.

Stories are summarized in plain language; follow the link before quoting a figure. Story images are shown from the publishers' own sites.